Nanoparticles in Ocular Drug Delivery Systems

Conventional ophthalmic formulations lack prolonged drug release effects and mucoadhesive properties, decreasing their residence time in the precorneal area and, therefore, in drug penetration across ocular tissues, presenting a low bioavailability with a consequent reduction in the therapeutic effi...

Full description

Saved in:

Bibliographic Details
Format:	Online
Language:	English
Published:	MDPI - Multidisciplinary Digital Publishing Institute 2023
Subjects:	nanotechnology fluorescence ocular delivery probes diagnostics PKs cyclodextrin ophthalmic fosinopril sodium niosomes encapsulation stabilization flash nanoprecipitation conjunctivitis nanoparticles zein hyaluronic acid ciprofloxacin topical ocular drug delivery transferosomes linoleic acid cyclosporine A nanoparticle drug-delivery systems retinal drug delivery inner limiting membrane photodisruption vapor nanobubbles indocyanine green pulsed laser tolnaftate spanlastics cosolvent fungal keratitis kill kinetics susceptibility cannabidiol nanoemulsion carbopol® 940 NF autoclave IOP rabbits corneal tissue engineering epithelium stroma endothelium 3D bioprinting ocular diseases sustained ocular delivery therapeutic proteins barriers of corneal tissues nanocarriers microcarriers cell-penetrating peptides hydrogels ocular drug delivery nebivolol open-angle glaucoma in situ gel Box Behnken design Poloxamer-407 kappa-carrageenan glaucoma chitosan mucoadhesion ocular bioavailability therapeutic efficacy triamcinolone acetonide nanocrystals ocular inflammation corticosteroids media milling n/a thema EDItEUR::M Medicine and Nursing thema EDItEUR::K Economics, Finance, Business and Management::KN Industry and industrial studies::KND Manufacturing industries
Online Access:	ONIX_20230714_9783036580036_56
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Nanoparticles in Ocular Drug Delivery Systems

Similar Items